MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,692,572 | +562.8% | 3,554,979 | +1114.6% | 0.03% | +800.0% |
| Q3 2021 | $708,000 | -90.9% | 292,692 | -88.1% | 0.00% | -91.2% |
| Q2 2021 | $7,796,000 | -65.6% | 2,459,399 | -63.4% | 0.03% | -65.3% |
| Q1 2021 | $22,646,000 | +4.9% | 6,719,948 | +11.4% | 0.10% | +21.0% |
| Q4 2020 | $21,588,000 | – | 6,030,293 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,029,649 | $12,331,000 | 0.54% |
| Vivo Capital, LLC | 778,000 | $2,381,000 | 0.17% |
| Logos Global Management LP | 200,000 | $612,000 | 0.12% |
| DAFNA Capital Management LLC | 76,800 | $235,000 | 0.07% |
| Verition Fund Management LLC | 395,290 | $1,210,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 250,000 | $765,000 | 0.02% |
| CSS LLC/IL | 54,773 | $168,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,148,000 | 0.01% |
| Marshall Wace North America L.P. | 267,180 | $818,000 | 0.01% |
| HHLR ADVISORS, LTD. | 124,970 | $382,000 | 0.00% |